tirzepatide a1c reduction Demonstrates 94% Diabetes Reduction, 22% Weight Loss in SURMOUNT-1 Study FDA Approves Tirzepatide, A Potential

However, as with any medical treatment, there is always a risk of side effects or complications

Participants receiving the 12 mg dose experienced an average weight loss of 8.96 kg (approximately 10%) over the 12-week study period

Diarrhea treatment in pregnancy Like diarrhea in people who are not pregnant, your diarrhea should clear up on its own in a few days if youre pregnant

The index date (day 0) was defined as the new initiation date of the index drug (semaglutide or a DPP4i)

Since its initial FDA approval, it has also been approved to reduce cardiovascular risk in adults with obesity or adults who are overweight with a weight-related health condition

However, most research is from animal studies